Our Portfolio

Companies We've Backed

At Kairos Ventures we seek to invest in passionate entrepreneurs with unique intellectual property in life and physical sciences. We focus on companies that are tackling difficult, potentially world changing problems. Here is a list of some of the companies that we are proud to have in our portfolio:

3D Bio Corporation Logo - Kairos Ventures Portfolio

3D Bio Corporation is shaping possibilities – to print what the body cannot heal. 3D Bio seeks a world in which healthy living tissue is no longer in short supply, and to open new paradigms for surgically healing patients.

Actinobac logo - Kairos Ventures Portfolio

Actinobac Biomed is a biopharmaceutical company developing therapeutics for multiple indications, including blood cancers, autoimmune/inflammatory diseases, and HIV.

Amorphology - Kairos Ventures Portfolio

Amorphology is using Bulk Metallic Glass, an amorphous metal alloy with unique glass-like properties, to create specialty gears for non-commercial robotics applications.

Applaud Medical Logo

Applaud Medical was established to develop an innovative new treatment for kidney stones, a condition diagnosed in more than 2 million individuals in the U.S. every year.

Axial Biotherapeutics

Axial Biotherapeutics is a biopharmaceutical company harnessing the link between the human gut microbiome and Central Nervous System to develop a new class of therapeutics to improve the quality of life for people with CNS diseases and disorders.

Behavioral Signals logo

Behavioral Signals provides award-winning emotion recognition and behavioral analytics technology based on a decade of research in cognitive modeling and advanced machine learning algorithms at the University of Southern California’s SAIL lab.

compellon logo

Compellon revolutionizes the modern approach to predictive analytics by delivering unprecedented speed and ease in knowledge discovery and model building.

Delpor Logo

Delpor develops the next generation Drug Delivery Systems which improve the clinical and commercial value of new and existing drugs and biopharmaceuticals.

Foldax is developing synthetic heart valves with the goal of delivering non-thrombogenic aortic and mitral valves at dramatically lower costs to existing artificial or tissue valves.

Gene Sciences Logo - Kairos Ventures Portfolio

Gene Sciences Inc. is developing novel DNA targeted therapeutics for the treatment of human genetic diseases.

Holoclara - Kairos Ventures Portfolio

Holoclara is an immunotherapy startup that aims to bring relief to people suffering from autoimmune disorders through the delivery of nematode derived molecules with potent therapeutic properties.

KMLabs - Kairos Ventures

KMLabs is the leading provider of the world’s most advanced femtosecond lasers, claiming the top universities and research institutions worldwide as its customers.

MemiRay - Kairos Ventures

MemiRay is a personal health monitoring device development organization with a novel approach to personal chemistry analysis that promises quantum leaps in convenience, portability, ease of use, regimen adherence, over-all health cost reduction, therapeutic outcome improvements and bio-hazardous waste management reduction.

NanoClear Logo

NanoClear Technologies has a proprietary process that can alter wettability of any arbitrary surface. The primary application of the technology is to provide anti-fogging capabilities in consumer wearables and anti-frost performance in a variety of industrial applications.

NeuroBioLogo - Kairos Ventures Portfolio

Neuro-Bio is an early stage biopharmaceutical company focused on developing novel, effective therapeutics for neurodegenerative disorders including Alzheimer’s, Parkinson’s and Motor Neuron Diseases.

Provivi - Kairos Ventures

Provivi’s mission is to provide disruptive chemistry solutions for agricultural, household, and professional pest control that are safe and environmentally benign.